Hypochlorite-Modified LDL Induces Arrhythmia and Contractile Dysfunction in Cardiomyocytes

Area of Science:

• Cardiovascular Biology
• Oxidative Stress
• Molecular Cardiology

Background:

• Neutrophil myeloperoxidase (MPO) and hypochlorous acid (HOCl) are implicated in cardiac damage.
• Cardiomyocytes produce low-density lipoprotein (LDL)-like particles, suggesting potential interactions with oxidized LDL.

Purpose of the Study:

• To identify the presence and impact of proatherogenic HOCl-modified LDL (HOCl-LDL) in human infarcted myocardium.
• To investigate the effects of HOCl-LDL on cardiomyocyte electrophysiology, contractility, and underlying molecular mechanisms.

Main Methods:

• Immunohistochemistry for MPO and HOCl-LDL in human myocardial tissue.
• Electrophysiological and contractility studies in primary and HL-1 cardiomyocytes.
• Immunoblotting, qPCR, and gene silencing to explore molecular pathways.

Main Results:

• HOCl-LDL altered ion channel function (reduced I_Ca,L, I_K1; increased I_NaL), causing action potential abnormalities and arrhythmias.
• HOCl-LDL impaired contractility and calcium homeostasis by affecting CaV1.2, RyR2, NCX1, and SERCA2a.
• LOX-1 signaling mediated increased superoxide and CaMKII oxidation by HOCl-LDL.

Conclusions:

• HOCl-LDL contributes significantly to cardiac dysfunction and remodeling in infarcted hearts.
• HOCl-LDL exerts detrimental effects on cardiac electrophysiology and contractility through oxidative stress and altered ion channel function.
• Targeting CaMKII and I_NaL may offer therapeutic strategies for HOCl-LDL-induced cardiac damage.